Verunsicherung um neue Alzheimertherapien

Two Alzheimer drugs targeting toxic protein deposits in the brain have raised hopes. However, a recent study indicates they offer little clinical benefit for patients and carry some risks. Experts criticize this portrayal as oversimplified and unsettling.